acyclovir

Generic: acyclovir

Labeler: quinn pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acyclovir
Generic Name acyclovir
Labeler quinn pharmaceuticals
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

acyclovir 200 mg/1

Manufacturer
Quinn Pharmaceuticals

Identifiers & Regulatory

Product NDC 69076-146
Product ID 69076-146_f03d714d-ed3a-60fc-e053-2995a90a3153
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075090
Listing Expiration 2026-12-31
Marketing Start 2021-05-27

Pharmacologic Class

Established (EPC)
herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc]
Mechanism of Action
dna polymerase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69076146
Hyphenated Format 69076-146

Supplemental Identifiers

RxCUI
197310
UPC
0369076146013
UNII
X4HES1O11F
NUI
N0000020060 N0000180187 N0000180188 N0000175468 N0000175459

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acyclovir (source: ndc)
Generic Name acyclovir (source: ndc)
Application Number ANDA075090 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (69076-146-01)
source: ndc

Packages (1)

Ingredients (1)

acyclovir (200 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f03d714d-ed3a-60fc-e053-2995a90a3153", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0369076146013"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["9ad711e4-003d-4b58-8177-32928bc42aa9"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Quinn Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (69076-146-01)", "package_ndc": "69076-146-01", "marketing_start_date": "20210527"}], "brand_name": "Acyclovir", "product_id": "69076-146_f03d714d-ed3a-60fc-e053-2995a90a3153", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "69076-146", "generic_name": "Acyclovir", "labeler_name": "Quinn Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA075090", "marketing_category": "ANDA", "marketing_start_date": "20210527", "listing_expiration_date": "20261231"}